Navigation Links
Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
Date:5/7/2012

nts at extreme risk by marketing Depakote for purposes not approved by the FDA and by paying kickbacks to induce doctors to write prescriptions," said Grant & Eisenhofer partner Reuben Guttman, who heads the firm's whistleblower practice. Mr. Guttman and Traci Buschner, senior counsel at Grant & Eisenhofer, served as lead counsel for Ms. McCoyd.

"Abbott's unlawful practices showed how the company elevated aggressive sales and marketing of Depakote over medical decision-making, violating basic norms of health care and ethics. Abbott essentially preyed on two of the most helpless patient populations in children and Alzheimer's patients," Mr. Guttman added.

"Abbott directed its sales force to get Depakote widely used in nursing homes, principally to neutralize older patients as a substitute for proper staffing," Mr. Guttman said. "We are extremely gratified that the Justice Department and participating state AGs ensured that Abbott would pay a significant penalty for its rampant off-label practices."

"With health care fraud projected to top $60 billion annually, cases such as this should serve as a catalyst for lawmakers to take a hard look at the pharmaceutical industry," Mr. Guttman continued. "What happened here with Abbott was a train wreck. Now is the time for Congress to create a pharmaceutical and medical device safety and investigation board, which would conduct investigations with an eye toward providing honest information and analysis to practitioners."

Mr. Guttman and Grant & Eisenhofer have been counsel in some of the most prominent False Claims cases in recent years, including recently representing Lynn Szymoniak, one of the key whistleblowers in the government's $25 billion settlement stemming from foreclosure abuses by the banking industry.

Mr. Guttman also represented one of principal whistleblowers in a False Claims case that led to the recovery of $2.3 billion
'/>"/>

SOURCE Grant & Eisenhofer
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. Northwest Bio Awarded $5.5 Million German Government Grant
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. Ultragenyx Granted Orphan Designations in Europe for Two Lead Product Candidates, UX001 for HIBM and UX003 for MPS 7
6. Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease
7. Esbriet® (pirfenidone) Benefit Granted by German Federal Joint Committee (G-BA)
8. Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation
9. Biovista Awarded Research Grant on Chronic Fatigue Syndrome From the CFIDS Association of America
10. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
11. U.S. FDA Grants Priority Review for XARELTO® (rivaroxaban) to Reduce Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... /PRNewswire-iReach/ -- Today leading web researchers Change Sciences Group ... web sites for usability, engagement, and conversion. The rankings ... which compares how people experience sites with competitors and ... The top three performers are easier to use, more ... performers have usability problems, lack aspects of design that ...
(Date:6/19/2013)... , June 19, 2013 Today MedeAnalytics, ... introduced the next-generation of its Employer Group ... health plans to provide their employer groups an ... factors, medical and prescription drug claims, network utilization, ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group ...
(Date:6/18/2013)... Quebec , June 18, 2013 Valeant ... TSX: VRX) (the "Company") announced today that VPII Escrow ... the Company, has launched its offer of approximately $3.2 ... "Notes").  The Notes will be due in 2021 and ... The Company intends to use the net proceeds ...
Breaking Medicine Technology:Sunovion tops new Change Sciences User Experience Rankings for Pharmaceutical Industry while McNeil-PPC ranks worst overall 2MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3
... 2011 When consumers are offered a cost-neutral choice ... store or through a mail-order pharmacy, they split their ... study from CVS Caremark (NYSE: CVS ) ... study, published in the January edition of the ...
... BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced ... BMN 701, a novel fusion protein of insulin-like growth factor ... treatment of Pompe disease. "We have a strong ... medical needs and expect to leverage our clinical and regulatory ...
Cached Medicine Technology:CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions 2CVS Caremark Study Evaluates Which Pharmacy Channel Consumers Choose When Given Choice of Mail or Retail Prescriptions 3BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease 2BioMarin Initiates Phase 1/2 Trial for BMN 701 for the Treatment of Pompe Disease 3
(Date:6/19/2013)... Children had half as many emergency department visits if ... five or more days a week, according to new ... Hospital and Johns Hopkins University. , The new study ... of Pediatrics and will be presented at the ... important step in understanding where primary care practices and ...
(Date:6/19/2013)... are increasingly common on college campuses, but are ... up"? A new study by researchers with The ... published online by the Archives of Sexual ... behaviors associated with sexual hookups, particularly among first-year ... negative emotional and physical health outcomes as a ...
(Date:6/19/2013)... block the body,s system for repairing damage to the ... unlikely as it may seem, those compounds are sparking ... driven by a mutation in BRCA, a gene that ... the mutation. The compounds, termed PARP inhibitors, are the ... of Chemical & Engineering News . C&EN is ...
(Date:6/19/2013)... Moffitt Cancer Center and colleagues at Louisiana State University ... that require immediate therapy. It relies on understanding the ... is to better predict a prostate cancer,s aggressiveness to ... published in the online journal PLOS ONE ... accounts for 20 percent of all cancers and 9 ...
(Date:6/19/2013)... Alternatives, a revolutionary new treatment facility located ... drugs while allowing them to continue drinking alcohol. Drs. ... believe that abstinence-only approaches force people to wait until ... this approach hurts instead of helping. It is ... need treatment for addiction but only 3 million seek ...
Breaking Medicine News(10 mins):Health News:Extended primary care office hours might help keep kids out of the emergency department 2Health News:Why are some college students more likely to 'hook up'? 2Health News:Moffitt Cancer Center researchers identify genetic variants predicting aggressive prostate cancers 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3
... way to treat castrate resistant cells in prostate cancer ... For more than 60 years the main way ... the hormones that fuel growth of the cancer cells. ... the tumour growth resumes, the disease in incurable. The ...
... , ... ... ... ...
... ... ... ... ...
... ... ... of complex government regulation some of the stand-out questions include:, , ,   ... How are these standards impacted by the convergence of media and conflation of traditional media ...
... ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Effective prostate cancer treatment discovery 2Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 2Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 3Health News:Verizon Health Care IT Experts to Present at Atlanta Conference on March 2, 3 4Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 2Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 3Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 4Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 5Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 6Health News:AFL-CIO President Richard Trumka to Discuss TSA Bargaining Rights on 'Inside Government' Radio Show 7Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 2Health News:Alan Chapell, President of Chapell & Associates to Deliver Keynote at the Next AdMonsters US Leadership Forum 3Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 2Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 3Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 4Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 5Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 6Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 7Health News:VIDEO from Medialink and American Lung Association: Don't Quit on Your Resolution to Quit Smoking! 8Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 2Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 3Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 4Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 5Health News:URAC Announces Open Public Comment Period for Expanded Independent Review Organization Accreditation 6
... Blood Collection Tubes are used ... blood samples for use with ... chemistry cartridges requiring either 95 ... sample. These tubes are Mylar-wrapped ...
... FEMTO LDV, the first compact, mobile femtosecond ... a versatile, powerful platform for a wide ... basic system addresses the demand of refractive ... is consistent with an efficient LASIK work-flow. ...
Safilo Design, a state-of-the art ophthalmic collection that blends technology with minimalist sophistication. Each style comes with a sleek silver-colored hard case with magnetic closure....
Classic, stylish, and preppy, this collection features men's, women's and unisex styles....
Medicine Products: